Diebold Nixdorf, Incorporated - stock earnings
Stock symbol DBD is outdated, potentially delisted? Maybe it is available on other exchange?
DBD Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q1 | -111.1 million USD | 858.1 million USD |
| 2022Q4 | -149.3 million USD | 968.8 million USD |
| 2022Q3 | -49.8 million USD | 810.4 million USD |
| 2022Q2 | -199.2 million USD | 851.7 million USD |
| 2022Q1 | -183.1 million USD | 829.8 million USD |
| 2021Q4 | -38.3 million USD | 1.1 billion USD |
| 2021Q3 | -2.1 million USD | 958.2 million USD |
| 2021Q2 | -30.3 million USD | 943.5 million USD |
| 2021Q1 | -8.1 million USD | 943.9 million USD |
| 2020Q4 | -51.2 million USD | 1.1 billion USD |
| 2020Q3 | -101.4 million USD | 995.2 million USD |
DBD Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -581.4 million USD | 3.5 billion USD |
| 2021 | -78.8 million USD | 3.9 billion USD |
| 2020 | -269.1 million USD | 3.9 billion USD |
| 2019 | -341.3 million USD | 4.4 billion USD |
| 2018 | -531.4 million USD | 4.6 billion USD |
| 2017 | -241.5 million USD | 4.6 billion USD |
DBD
Price: $17.97
52 week price:
Dividend Yield: 4.62%
Payout Ratio Range:
Earnings Per Share: 1.19 USD
P/E Ratio: -7.68
Exchange: NYQ
Sector: Technology
Industry: Software - Application
Volume: 1.9 million
Ebitda: 81.7 millionMarket Capitalization: 76.9 million